APPLICATION
ANDA061773
TYPE
ANDA
ORIGINAL APPROVAL
1973-11-02
LATEST ACTION
2008-05-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
KEFZOLDiscontinued
CEFAZOLIN SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION
KEFZOLDiscontinued
CEFAZOLIN SODIUM EQ 20GM BASE/VIAL · INJECTABLE · INJECTION
KEFZOLDiscontinued
CEFAZOLIN SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
KEFZOLDiscontinued
CEFAZOLIN SODIUM EQ 250MG BASE/VIAL · INJECTABLE · INJECTION
KEFZOLDiscontinued
CEFAZOLIN SODIUM EQ 10GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2008-05-29Labeling · Supplement 66AP
2002-09-18Manufacturing (CMC) · Supplement 63AP
1999-03-03Labeling · Supplement 59AP
1999-03-03Manufacturing (CMC) · Supplement 58AP
1993-07-15Labeling · Supplement 56AP
1993-04-02Manufacturing (CMC) · Supplement 54AP
1992-10-07Labeling · Supplement 53AP
1992-06-29Labeling · Supplement 52AP
1991-11-21Labeling · Supplement 47AP
1991-11-21Labeling · Supplement 48AP
1991-10-29Manufacturing (CMC) · Supplement 49AP
1991-10-29Manufacturing (CMC) · Supplement 51AP
1991-07-25Labeling · Supplement 46AP
1991-07-10Manufacturing (CMC) · Supplement 50AP
1991-07-10Manufacturing (CMC) · Supplement 45AP
1973-11-02OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.